Background: The rapid expansion and popularity of consumer-wearable physical activity monitors (WPAMs) has enabled the integration of technology into physical activity (PA) intervention, deployment, and evaluation. This brief review reports on the accuracy of consumer-WPAMs, considers the intervention effects of using consumer-WPAMs, and offers future considerations as the proliferation of this area of product development and consumer use continues to escalate.
Content: The studies reviewed document the utility for consumer-WPAMs to objectively assess PA, with output metrics similar to research-grade activity monitors. Early intervention efficacy for the use of consumer-WPAMs to increase PA holds considerable promise. Substantial increases in moderate- to vigorous-intensity PA (MVPA) have been reported across different research study designs and populations in which consumer-WPAMs have been used in isolation or in conjunction with other behavioral change strategies. The utility of consumer-WPAMs is currently being investigated in clinical populations, notably showing increases in PA in individuals at risk for cancer or post cancer survivors, in those with chronic obstructive pulmonary disease, and in postsurgical patients. There has been a proliferation of registered trials at clinicaltrials.gov, and an increase of disseminated works regarding the use of consumer-WPAMs is expected.
Summary: There are many research studies documenting the validity and intervention effectiveness of consumer-WPAMs; evidence is emerging on the health benefits linked to use of such devices. Future work on the long-term effects of consumer-WPAMs on behavior and health is warranted, and prospects appear exciting as wearable technology advances and adoption increases.
© 2017 American Association for Clinical Chemistry.